Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLN3897 in active rheumatoid arthritis on background methotrexate
NL-OMON27198Phase 2Active, not recruiting
- Sponsor
- Takeda
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing MLN3897 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoints: ACR20 response at Day 84 and Safety assessments. Started Sep 2006; status: active, not recruiting.
02
Drugs
MLN3897
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON27198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27198.